Basic info
Industry
biotechnology research
Sectors
Biotechnology
Therapeutics
Central Nervous System
Cannabis addiction
Cognitive Disorders
Innovative signaling specific drugs
CB1 receptor
Fragil X syndrom
Down syndrome
Allosteric modulator
Date founded
2013
Funding rounds raised
Total raised
$12M
from 2 investors over 2 rounds
A
AELIS FARMA raised $10M on December 13, 2019
Investors: The National Institute on Drug Abuse (NIDA)
A
AELIS FARMA raised $12M on December 13, 2019
Investors: Région Nouvelle-Aquitaine